RNA therapeutics

CAMBRIDGE, Massachusetts, March 25, 2026 Sarepta Therapeutics has announced first clinical data from its next-generation siRNA pipeline, demonstrating robust...

BASEL, Switzerland – February 27, 2026 Novartis AG has successfully completed its acquisition of Avidity Biosciences, Inc., strengthening its...

SAN DIEGO, Calif., February 26, 2026 Avidity Biosciences, Inc. (Nasdaq: RNA) announced that it will present one oral and...

NEW YORK, Feb. 12, 2026 — Hoth Therapeutics announced that the U.S. Patent and Trademark Office has issued a...

Amsterdam, Netherlands | February 9 2026 — Vectory Therapeutics has announced that the first participant has been dosed in...

SAN FRANCISCO, December 3, 2025 — Junevity today announced the expansion of its seed funding round to $20 million...

Dateline IntroductionNovember 17, 2025 — Marlborough, Massachusetts — Phio Pharmaceuticals Corp., a clinical-stage biopharmaceutical company advancing RNA-based immuno-oncology therapeutics,...

Dateline — King of Prussia, Pennsylvania, November 7, 2025:Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has announced new clinical data from...

CAMBRIDGE, Mass., November 4, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company pioneering the use...

San Francisco, California – November 3, 2025 Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on harnessing...